fosamprenavir has been researched along with spironolactone in 1 studies
Studies (fosamprenavir) | Trials (fosamprenavir) | Recent Studies (post-2010) (fosamprenavir) | Studies (spironolactone) | Trials (spironolactone) | Recent Studies (post-2010) (spironolactone) |
---|---|---|---|---|---|
174 | 55 | 37 | 7,222 | 960 | 1,923 |
Protein | Taxonomy | fosamprenavir (IC50) | spironolactone (IC50) |
---|---|---|---|
Chain A, Mineralocorticoid receptor | Homo sapiens (human) | 0.049 | |
Chain A, Mineralocorticoid receptor | Homo sapiens (human) | 0.049 | |
Estrogen receptor | Homo sapiens (human) | 5.702 | |
Glucocorticoid receptor | Homo sapiens (human) | 4.0745 | |
Progesterone receptor | Homo sapiens (human) | 1.675 | |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 1.9025 | |
Mineralocorticoid receptor | Homo sapiens (human) | 0.0315 | |
Androgen receptor | Homo sapiens (human) | 0.3585 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 0.406 | |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 1.9025 | |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 1.9025 | |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 1.9025 | |
Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 6.92 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for fosamprenavir and spironolactone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |